Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas G Widman

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Expert Review of Vaccines|September 25, 2014
Dengue virus envelope protein domain I/II hinge: a key target for dengue virus vaccine design?Douglas G Widman, Ralph S Baric
Advances in Virus Research|December 17, 2008
Third-generation flavivirus vaccines based on single-cycle, encapsidation-defective virusesDouglas G Widman, Ilya Frolov, Peter W Mason
Plos One|October 18, 2018
In vitro toxicity and efficacy of verdinexor, an exportin 1 inhibitor, on opportunistic viruses affecting immunocompromised individualsDouglas G Widman, Savanna Gornisiewicz, Sharon Shacham, et al.
Virology|October 18, 2011
Analyses of mutations selected by passaging a chimeric flavivirus identify mutations that alter infectivity and reveal an interaction between the structural proteins and the nonstructural glycoprotein NS1Evandro R Winkelmann, Douglas G Widman, Ryosuke Suzuki, et al.
Vaccine|April 25, 2008
Construction and evaluation of a chimeric pseudoinfectious virus vaccine to prevent Japanese encephalitisTomohiro Ishikawa, Douglas G Widman, Nigel Bourne, et al.
Vaccine|April 22, 2008
Construction and characterization of a second-generation pseudoinfectious West Nile virus vaccine propagated using a new cultivation systemDouglas G Widman, Tomohiro Ishikawa, Rafik Fayzulin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 23, 2011
Repeated in vivo stimulation of T and B cell responses in old mice generates protective immunity against lethal West Nile virus encephalitisJennifer L Uhrlaub, James D Brien, Douglas G Widman, et al.
Vaccine|July 29, 2009
RepliVAX WN, a single-cycle flavivirus vaccine to prevent West Nile disease, elicits durable protective immunity in hamstersDouglas G Widman, Tomohiro Ishikawa, Evandro R Winkelmann, et al.
Vaccine|July 30, 2011
Enhancing the utility of a prM/E-expressing chimeric vaccine for Japanese encephalitis by addition of the JEV NS1 geneTomohiro Ishikawa, Gongbo Wang, Douglas G Widman, et al.
Virology|February 8, 2014
Subcapsular sinus macrophages limit dissemination of West Nile virus particles after inoculation but are not essential for the development of West Nile virus-specific T cell responsesEvandro R Winkelmann, Douglas G Widman, Jingya Xia, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Expert Review of Vaccines|September 25, 2014
Dengue virus envelope protein domain I/II hinge: a key target for dengue virus vaccine design?Douglas G Widman, Ralph S Baric
Advances in Virus Research|December 17, 2008
Third-generation flavivirus vaccines based on single-cycle, encapsidation-defective virusesDouglas G Widman, Ilya Frolov, Peter W Mason
Plos One|October 18, 2018
In vitro toxicity and efficacy of verdinexor, an exportin 1 inhibitor, on opportunistic viruses affecting immunocompromised individualsDouglas G Widman, Savanna Gornisiewicz, Sharon Shacham, et al.
Virology|October 18, 2011
Analyses of mutations selected by passaging a chimeric flavivirus identify mutations that alter infectivity and reveal an interaction between the structural proteins and the nonstructural glycoprotein NS1Evandro R Winkelmann, Douglas G Widman, Ryosuke Suzuki, et al.
Vaccine|April 25, 2008
Construction and evaluation of a chimeric pseudoinfectious virus vaccine to prevent Japanese encephalitisTomohiro Ishikawa, Douglas G Widman, Nigel Bourne, et al.
Vaccine|April 22, 2008
Construction and characterization of a second-generation pseudoinfectious West Nile virus vaccine propagated using a new cultivation systemDouglas G Widman, Tomohiro Ishikawa, Rafik Fayzulin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 23, 2011
Repeated in vivo stimulation of T and B cell responses in old mice generates protective immunity against lethal West Nile virus encephalitisJennifer L Uhrlaub, James D Brien, Douglas G Widman, et al.
Vaccine|July 29, 2009
RepliVAX WN, a single-cycle flavivirus vaccine to prevent West Nile disease, elicits durable protective immunity in hamstersDouglas G Widman, Tomohiro Ishikawa, Evandro R Winkelmann, et al.
Vaccine|July 30, 2011
Enhancing the utility of a prM/E-expressing chimeric vaccine for Japanese encephalitis by addition of the JEV NS1 geneTomohiro Ishikawa, Gongbo Wang, Douglas G Widman, et al.
Virology|February 8, 2014
Subcapsular sinus macrophages limit dissemination of West Nile virus particles after inoculation but are not essential for the development of West Nile virus-specific T cell responsesEvandro R Winkelmann, Douglas G Widman, Jingya Xia, et al.
Pageof 3